{"input_url":"https://ca.news.yahoo.com/fda-advisory-panel-votes-place-220009348.html","gnews_decode":"https://ca.news.yahoo.com/fda-advisory-panel-votes-place-220009348.html","http_status":200,"final_url":"https://ca.news.yahoo.com/fda-advisory-panel-votes-place-220009348.html","html_length":335392,"trafilatura_result":"ok","text_length":471,"text_preview":"July 23 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a popular peptide called TB-500 on a list that would allow broader pharmacy compounding.\nEight panel members voted in favor, while six voted against. One member abstained.\nThe FDA is not bound","verdict":"OK"}